Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Role of Natural Products for the Treatment of Alzheimer's Disease Publisher Pubmed



Noori T1 ; Dehpour AR2, 3 ; Sureda A4, 5 ; Sobarzosanchez E6, 7 ; Shirooie S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Experimental Medicine Research Center, TUMS, Tehran, Iran
  4. 4. Research Group on Community Nutrition and Oxidative Stress (NUCOX), University Research Institute of Health Sciences (IUNICS), and Health Research Institute of Balearic Islands (IdISBa), University of Balearic Islands, Palma de Mallorca, E-07122, Balearic Islands, Spain
  5. 5. CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain
  6. 6. Instituto de Investigacion y Postgrado, Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago, Chile
  7. 7. Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, Spain

Source: European Journal of Pharmacology Published:2021


Abstract

Negative psychological and physiological consequences of neurodegenerative disorders represent a high social and health cost. Among the neurodegenerative disorders Alzheimer's disease (AD) is recognized as a leading neurodegenerative condition and a primary cause of dementia in the elderlys. AD is considered as neurodegenerative disorder that progressively impairs cognitive function and memory. According to current epidemiological data, about 50 milLion people worldwide are suffering from AD. The primary symptoms of AD are almost inappreciable and usually comprise forgetfulness of recent events. Numerous processes are involved in the development of AD, for example oxidative stress (OS) mainly due to mitochondrial dysfunction, intracellular the accumulation of hyperphosphorylated tau (τ) proteins in the form of neurofibrillary tangles, excessive the accumulation of extracellular plaques of beta-amyloid (Aβ), genetic and environmental factors. Running treatments only attenuate symptoms and temporarily reduce the rate of cognitive progression associated with AD. This means that most treatments focus only on controlLing symptoms, particularly in the initial stages of the disease. In the past, the first choice of treatment was based on natural ingredients. In this sense, diverse natural products (NPs) are capable to decrease the symptoms and alleviate the development of several diseases including AD attracting the attention of the scientific community and the pharmaceutical industry. Specifically, numerous NPs including flavonoids, gingerols, tannins, anthocyanins, triterpenes and alkaloids have been shown anti-inflammatory, antioxidant, anti-amyloidogenic, and anti-choLinesterase properties. This review provide a summary of the pathogenesis and the therapeutic goals of AD. It also discusses the available data on various plants and isolated natural compounds used to prevent and diminish the symptoms of AD. © 2021 Elsevier B.V.
Related Docs
View other Related Docs
1. Total Scale Analysis of Organic Acids and Their Role to Mitigate Alzheimer's Disease, South African Journal of Botany (2022)
2. Tau Immunotherapy in Alzheimer's Disease and Progressive Supranuclear Palsy, International Immunopharmacology (2022)
3. Protective Effects of Flavonoids Against Alzheimer's Disease-Related Neural Dysfunctions, Biomedicine and Pharmacotherapy (2017)
4. Biosensors for Detection of Tau Protein As an Alzheimer's Disease Marker, International Journal of Biological Macromolecules (2020)
5. Caffeine and Mitochondria With a Focus on the Central Nervous System, Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health (2021)
6. Effects of Cinnamon Oil and Its Main Constituents, Cinnamic Acid and Cinnamaldehyde, on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurodegeneration in Pc-12 Cells; [Efectos Del Aceite De Canela Y Sus Principales Componentes, Acido Cinamico Y Cinamaldehido En La Neurodegeneracion Inducida Por 1-Metil-4-Fenil-1,2,3,6-Tetrahidropiridina En Celulas Pc 12], Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas (2023)
7. Pistacia Genus As a Potential Source of Neuroprotective Natural Products, Planta Medica (2019)
8. Micrornas Modulation by Curcumin, Catalpol, and Other Natural Products in Alzheimer’S Disease: A Review, Molecular Biology Reports (2025)
Experts (# of related papers)
View all Related Experts
Mohammad Abdollahi (5)
Alireza Foroumadi (3)
Other Related Docs
9. Combination Therapy in Alzheimer's Disease: Is It Time?, Journal of Alzheimer's Disease (2022)
10. Early Diagnosis of Alzheimer’S Disease With Blood Test; Tempting But Challenging, International Journal of Molecular and Cellular Medicine (2023)
11. Medicinal Plants and Their Isolated Phytochemicals for the Management of Chemotherapy-Induced Neuropathy: Therapeutic Targets and Clinical Perspective, DARU# Journal of Pharmaceutical Sciences (2019)
12. Protective Effects of Plant-Derived Compounds Against Traumatic Brain Injury, Molecular Neurobiology (2024)
13. Design and Synthesis of New 1,2,3-Triazole-Methoxyphenyl-1,3,4-Oxadiazole Derivatives: Selective Butyrylcholinesterase Inhibitors Against Alzheimer’S Disease, BMC Chemistry (2025)
14. Chromone–Lipoic Acid Conjugate: Neuroprotective Agent Having Acceptable Butyrylcholinesterase Inhibition, Antioxidant and Copper-Chelation Activities, DARU# Journal of Pharmaceutical Sciences (2021)
15. New Racemic Annulated Pyrazolo[1,2-B]Phthalazines As Tacrine-Like Ache Inhibitors With Potential Use in Alzheimer's Disease, European Journal of Medicinal Chemistry (2017)
16. Effects of Berberine Hydrochloride on Methamphetamine-Induced Anxiety Behaviors and Relapse in Rats, Iranian Journal of Basic Medical Sciences (2020)
17. The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review, Journal of Molecular Neuroscience (2018)
18. The Effect of Insomnia on Development of Alzheimer's Disease, Journal of Neuroinflammation (2020)
19. The Beneficial Effects of Hmg-Coa Reductase Inhibitors in the Processes of Neurodegeneration, Metabolic Brain Disease (2017)
20. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives As Anti-Acetylcholinesterase Agents, Chemistry and Biodiversity (2021)
21. Huperzine a Ameliorates Cognitive Dysfunction and Neuroinflammation in Kainic Acid-Induced Epileptic Rats by Antioxidant Activity and Nlrp3/Caspase-1 Pathway Inhibition, Clinical and Experimental Pharmacology and Physiology (2019)
22. Air Pollution: A Latent Key Driving Force of Dementia, BMC Public Health (2024)
23. Cinnamon, a Promising Prospect Towards Alzheimer's Disease, Pharmacological Research (2018)
24. Can Any “Non-Specific Charge Modification Within Microtubule Binding Domains of Tau” Be a Prerequisite of the Protein Amyloid Aggregation? an in Vitro Study on the 1N4r Isoform, International Journal of Biological Macromolecules (2018)
25. Common Herbal Treatments for Senile Dementia in Ancient Civilizations: Greco-Roman, Chinese, Indian, and Iranian, Journal of Medicinal Plants (2020)
26. Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders, Frontiers in Bioengineering and Biotechnology (2020)
27. Phosphodiesterase Inhibitors Say No to Alzheimer's Disease, Food and Chemical Toxicology (2019)
28. Use of Drugs Affecting Gabaa Receptors and the Risk of Developing Alzheimer’S Disease and Dementia: A Meta-Analysis and Literature Review, Molecular Neurobiology (2025)
29. Age-Related Macular Degeneration and Neurodegenerative Disorders: Shared Pathways in Complex Interactions, Survey of Ophthalmology (2024)
30. Dietary Choline and Betaine Intake and Risk of Colorectal Cancer in an Iranian Population, Cancers (2023)
31. Dose-Dependent Manner of Luteolin in the Modulation of Spatial Memory With Respect to the Hippocampal Level of Hsp70 and Hsp90 in Sleep-Deprived Rats, Gene (2023)
32. Aminoalkyl-Substituted Flavonoids: Synthesis, Cholinesterase Inhibition, Β-Amyloid Aggregation, and Neuroprotective Study, Medicinal Chemistry Research (2019)